Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

US Patent 9029559 · Granted May 12, 2015

Estimated economic value: $25,802,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity,2019
Method for loading executable program instructions into a chip card during activ2019
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obes2018
Substituted indanone compounds as GPR119 modulators for the treatment of diabete2018
Fused pyrroledicarboxamides and their use as pharmaceuticals2018
Substituted fused heterocycles as GPR119 modulators for the treatment of diabete2017
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals2017
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals2017
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals2017
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals2017
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals2017
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa2017